Amy Rabourn
Treasurer at OCUPHIRE PHARMA, INC.
Net worth: 11 823 $ as of 30/04/2024
Profile
Amy Rabourn is currently the Treasurer & Senior Vice President-Finance at Ocuphire Pharma, Inc. Prior to her current position, she worked as the Finance Director at Gemphire Therapeutics, Inc. from 2014 to 2019.
Ms. Rabourn has an undergraduate and graduate degree from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
0.03% | 15/04/2024 | 7,702 ( 0.03% ) | 11 823 $ | 30/04/2024 |
Amy Rabourn active positions
| Companies | Position | Start |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - |
Former positions of Amy Rabourn
| Companies | Position | End |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/12/2019 |
Training of Amy Rabourn
| University of Michigan | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Stock Market
- Insiders
- Amy Rabourn
